Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.51 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | DRD1 | P21728 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10892150 | 0.88 | ELANE (0.43) | ELANEABCB1DRD2DRD1DRD3 | |
| SCHEMBL3316012 | 0.85 | KDM4E (0.65) | POLBKDM4EHTTMAPTMEN1 | |
| SCHEMBL16966571 | 0.85 | KDM4E (0.65) | POLBKDM4EHTTMAPTMEN1 | |
| SCHEMBL11058652 | 0.84 | PTGDR2 (0.54) | ABCB1PTGDR2POLBMEN1KMT2A | |
| SCHEMBL3314748 | 0.84 | KDM4E (0.63) | POLBKDM4EHTTMAPTMEN1 | |
| SCHEMBL867129 | 0.83 | PTGDR2 (0.68) | ELANEABCB1DRD2DRD1DRD3 | |
| SCHEMBL29388652 | 0.83 | PTGDR2 (0.68) | ELANEABCB1DRD2DRD1DRD3 | |
| SCHEMBL11056067 | 0.83 | POLB (0.71) | ELANEPTGDR2POLBKDM4EHTT | |
| SCHEMBL6928774 | 0.82 | ABCB1 (0.49) | ELANEABCB1DRD2DRD1DRD3 | |
| SCHEMBL14092915 | 0.82 | KDM4E (0.46) | ABCB1POLBKDM4EHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114127216-B | Pressure-sensitive adhesive sheet and use thereof | 日东电工株式会社 | 2025-02-25 | — | — | CN | disclosed |
| US-12215258-B2 | Pressure-sensitive adhesive sheet and use thereof | NITTO DENKO CORPORATION (JP) | 2025-02-04 | — | — | US | disclosed |
| CN-113412317-B | Pressure-sensitive adhesive sheet | 日东电工株式会社 | 2023-11-28 | — | — | CN | disclosed |
| US-20230002409-A1 | MACROCYCLIC FLU ENDONUCLEASE INHIBITORS | JANSSEN BIOPHARMA INC (US) | 2023-01-05 | — | — | US | disclosed |
| US-20230002409-A1 | MACROCYCLIC FLU ENDONUCLEASE INHIBITORS | JANSSEN BIOPHARMA INC (US) | 2023-01-05 | — | — | US | disclosed |
| US-20220275254-A1 | PRESSURE-SENSITIVE ADHESIVE SHEET AND USE THEREOF | NITTO DENKO CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| US-20220195256-A1 | PRESSURE-SENSITIVE ADHESIVE SHEET | NITTO DENKO CORPORATION (JP) | 2022-06-23 | — | — | US | disclosed |
| US-11312727-B1 | Macrocyclic flu endonuclease inhibitors | Janssen Biopharma, Inc. (US) | 2022-04-26 | — | — | US | disclosed |
| US-11312727-B1 | Macrocyclic flu endonuclease inhibitors | Janssen Biopharma, Inc. (US) | 2022-04-26 | — | — | US | disclosed |
| US-20220119685-A1 | PRESSURE-SENSITIVE ADHESIVE SHEET | NITTO DENKO CORPORATION (JP) | 2022-04-21 | — | — | US | disclosed |
| EP-2277965-A2 | Removable pressure-sensitive adhesive composition and pressure-sensitive adhesive tape or sheet | Nitto Denko Corporation (JP) | 2011-01-26 | — | — | EP | disclosed |
| WO-2010112474-A1 | COATING COMPOSITION, (METH)ACRYL-POLYMER AND MONOMER MIXTURE FOR PRODUCING SAID (METH)ACRYL-POLYMER | EVONIK RÖHM GMBH (DE) | 2010-10-07 | — | — | WO | disclosed |
| US-20080138618-A1 | REMOVABLE PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND PRESSURE-SENSITIVE ADHESIVE TAPE OR SHEET | NITTO DENKO CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1930386-A2 | Removable pressure-sensitive adhesive composition and pressure-sensitive adhesive tape or sheet | NITTO DENKO CORPORATION (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-0367054-B1 | UV CROSSLINKABLE COMPOSITION BASED ON COPOLYMERS OF ISOAMYL (METH)ACRYLATES | BASF Aktiengesellschaft (DE) | 1993-06-23 | — | — | EP | disclosed |
| US-5026806-A | Hot melt adhesives | BASF AKTIENGESELLSCHAFT (DE) | 1991-06-25 | — | — | US | disclosed |
| EP-0367054-A2 | UV crosslinkable composition based on copolymers of isoamyl (meth)acrylates | BASF Aktiengesellschaft (DE) | 1990-05-09 | — | — | EP | disclosed |
| EP-0088842-B1 | ORGANOPOLYSILOXANE PHOTOSENSITIZERS AND METHODS FOR THEIR PREPARATION | Toray Silicone Company Limited (JP) | 1986-01-02 | — | — | EP | disclosed |
| US-4467082-A | Organopolysiloxane photosensitizers and methods for their preparation | DOW CORNING CORPORATION (US) | 1984-08-21 | — | — | US | disclosed |
| EP-0088842-A1 | Organopolysiloxane photosensitizers and methods for their preparation | Toray Silicone Company Limited (JP) | 1983-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002409-A1 | MACROCYCLIC FLU ENDONUCLEASE INHIBITORS | ACE, PNP, FEN1 | ELANE 481/4885ABCB1 800/4885DRD2 4555/4885 |
| US-11312727-B1 | Macrocyclic flu endonuclease inhibitors | ACE, FEN1, PNP | ELANE 382/4885ABCB1 794/4885DRD2 4690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.